COVID-19 Vaccine

A Vanderbilt study finds that Moderna’s COVID-19 vaccine is safe and effective in children 6 months to 5 years of age. Read More

A collaborative team of Vanderbilt researchers has characterized the antigen-specific immune response to the Pfizer SARS-CoV-2 RNA vaccine. The group used multiple single-cell technologies, unbiased machine learning and traditional immunological approaches to track cellular and antibody responses in samples collected over time from a cohort of healthy participants. Read More

The U.S. Food and Drug Administration is expected to authorize Pfizer and Moderna’s COVID-19 vaccines for children as young as 6 months old. Read More

Moderna’s COVID-19 vaccine is safe and generates robust immune responses in children ages 6 to 11 years, a national clinical trial co-led by C. Buddy Creech, MD, MPH, has found. Read More

Additional booster doses of vaccine against COVID-19 are particularly important for those who are immunosuppressed, namely those who have had solid organ transplants, a new study shows. Read More

Vanderbilt University professor Carolyn Heinrich and colleagues conducted research to examine interactions between people inquiring about how to get a COVID-19 vaccine with state agencies and major vaccination sites. Their findings are newly published online in the journal "Social Science & Medicine." Read More

Vanderbilt research shows that two doses of an mRNA COVID-19 vaccine result in lower effectiveness for preventing hospitalization for the omicron variant than previous variants. However, importantly, a third (“booster”) vaccine dose significantly improves protection against omicron hospitalization up to 86%. Read More

Assistant Professors of Nursing Christian Ketel and Carrie Plummer have received Vanderbilt’s 2022 Martin Luther King Jr. Award for developing and leading the Vanderbilt University School of Nursing/Vanderbilt University Medical Center Mobile Vaccine Program. Read More

Vanderbilt's Mobile Vaccine Program grew quickly from a successful pilot in Nashville’s Mercury Courts community, where School of Nursing and VUMC have long run a clinic for homeless and low-income patients. The vaccine program has attracted participation from Vanderbilt faculty, staff and student volunteers as well as pharmacy students and faculty at nearby universities. Read More

The U.S. Food and Drug Administration granted emergency use authorization Dec. 8 to the global biopharmaceutical company AstraZeneca for a long-acting antibody combination that protects against COVID-19, discovered last year at Vanderbilt University Medical Center. Read More

Charles Sanders, associate dean for research and professor of biochemistry and medicine, describes how breakthrough infections occur even for those who have been fully vaccinated against COVID-19. Read More

Charles Sanders, associate dean for research and professor of biochemistry and medicine, explains the similarities and differences between the “third dose” and “booster” vaccinations for COVID-19. Read More

The Division of Administration recently conducted a drawing for 25 Vanderbilt University-employed staff and postdoctoral scholars who submitted their COVID-19 vaccination record to the university before July 19. Each winner will receive $1,000. Read More

Vanderbilt University is requiring all university–employed faculty, staff and postdoctoral fellows to be fully vaccinated against COVID-19 for the 2021-22 academic year. The deadline for faculty, staff and postdocs to submit their full vaccination record is Saturday, July 31. Read More

The Vanderbilt Occupational Health Clinic is now offering the COVID-19 vaccine to Vanderbilt faculty, staff and postdoctoral scholars on a walk-in basis. Those who need their first or second dose of the Pfizer vaccine may walk in to the Occupational Health Clinic vaccination location on the sixth floor of the Medical Arts Building. Read More

Vanderbilt University today announced it will require new and returning students to be fully vaccinated against COVID-19 for the 2021–22 academic school year. The requirement applies to all undergraduate,  graduate  and professional students this fall, and it will be handled in a manner consistent with other university policies governing student vaccine requirements. Read More

A student-led group called the Vanderbilt Initiative for Public Health Equality is partnering with the Division of Administration to reduce COVID-19 vaccine hesitancy within the campus community. Read More

The remarkable success of the COVID-19 vaccines began in a Vanderbilt lab decades ago, with the groundbreaking research of alumnus Dr. Barney Graham. Read More

Vanderbilt first-year students recently met with Buddy Creech, director of the Vanderbilt Vaccine Research Program and associate professor of pediatrics, for a special virtual chat to answer some of their COVID-19 vaccine questions. Read More

Vanderbilt Occupational Health has created a COVID-19 frequently asked questions page to answer employees’ queries about what to do if exposed to COVID-19, as well as provide information about the COVID-19 vaccination. Read More